During the past decade, Adventist Midwest Health conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adventist Midwest Health" #1 sponsor was "Sirtex Medical" with 2 trials, followed by "American Hip Institute" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Goldfinch Bio, Inc." with 1 trials sponsored and "Medtronic Cardiovascular" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adventist Midwest Health" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "BSN Medical Inc" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Adventist Midwest Health" are "Deep Vein Thrombosis" (2 trials), "ABDOMINAL AORTIC ANEURYSMS" (1 trials), "Aneuploidy" (1 trials), "Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Adventist Midwest Health" in a lesser frequency.

Most popular intervention types in "Adventist Midwest Health" are "Device" (6 trials), "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.25% Bupivacaine with epinephrine" (1 trials), "AneuRx AAA stent graft / Talent AAA stent graft" (1 trials), "Balloon kyphoplasty" (1 trials), "Blood Draw" (1 trials) and "FOLFOX6m" (1 trials). Other intervention names were less common.

The vast majority of trials in "Adventist Midwest Health" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Adventist Midwest Health". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Adventist Midwest Health, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Adventist Midwest Health, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".